You have 9 free searches left this month | for more free features.

TTI-622

Showing 1 - 25 of 38

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Lymphoma, Multiple Myeloma Trial in Nagoya, Koto, Yamagata (TTI-622)

Recruiting
  • Lymphoma
  • Multiple Myeloma
  • TTI-622
  • Nagoya, Aichi, Japan
  • +2 more
Jan 20, 2023

Multiple Myeloma Trial in United States (TTI-622, Daratumumab Hyaluronidase-fihj)

Recruiting
  • Multiple Myeloma
  • TTI-622
  • Daratumumab Hyaluronidase-fihj
  • Basking Ridge, New Jersey
  • +6 more
Dec 8, 2022

Recurrent ALK Positive Large B-Cell Lymphoma, Recurrent B-Cell Lymphoma, Unclassifiable, With Features Intermediate Between

Not yet recruiting
  • Recurrent ALK Positive Large B-Cell Lymphoma
  • +28 more
  • Biospecimen Collection
  • +5 more
  • Rochester, Minnesota
    Mayo Clinic in Rochester
Aug 17, 2022

Ovarian Cancer, Ovarian Tumors, Ovarian Carcinoma Trial in Santa Monica, Pittsburgh, Houston (TTI-622, Pegylated Liposomal

Recruiting
  • Ovarian Cancer
  • +5 more
  • TTI-622
  • Pegylated Liposomal Doxorubicin
  • Santa Monica, California
  • +4 more
Jul 26, 2022

Non-Hodgkin Lymphoma, Multiple Myeloma Trial in China (Maplirpacept)

Not yet recruiting
  • Non-Hodgkin Lymphoma
  • Multiple Myeloma
  • Beijing, Beijing, China
  • +3 more
May 31, 2023

Lymphoma, Multiple Myeloma, Acute Myeloid Leukemia Trial in United States (TTI-622, Azacitidine, Venetoclax)

Recruiting
  • Lymphoma
  • +3 more
  • TTI-622
  • +6 more
  • Los Angeles, California
  • +36 more
Jan 23, 2023

Breast Cancer Trial in Canton (TTI-101, Palbociclib, Aromatase inhibitor (AI))

Recruiting
  • Breast Cancer
  • Saint Louis, Missouri
  • +2 more
Jan 12, 2023

Pancreatic Cancer Trial in Aurora (TTI-101)

Not yet recruiting
  • Pancreatic Cancer
  • Aurora, Colorado
    University of Colorado
Nov 30, 2023

Squamous Cell Carcinoma of Head and Neck Trial in Houston (Control Group, TTI-101)

Not yet recruiting
  • Squamous Cell Carcinoma of Head and Neck
  • Houston, Texas
    M D Anderson Cancer Centerl
Apr 25, 2023

Head and Neck Squamous Cell Carcinoma Trial (TTI-101, Pembrolizumab)

Not yet recruiting
  • Head and Neck Squamous Cell Carcinoma
  • (no location specified)
Dec 20, 2022

Hepatocellular Carcinoma Trial (TTI-101, Pembrolizumab, Atezolizumab)

Not yet recruiting
  • Hepatocellular Carcinoma
  • (no location specified)
Jun 30, 2022

COVID-19, COVID-19 Acute Respiratory Distress Syndrome Trial (TTI-0102, Placebo)

Not yet recruiting
  • COVID-19
  • COVID-19 Acute Respiratory Distress Syndrome
  • (no location specified)
May 13, 2022

Idiopathic Pulmonary Fibrosis Trial (TTI-101, Placebo)

Not yet recruiting
  • Idiopathic Pulmonary Fibrosis
  • (no location specified)
Jan 3, 2023

Leiomyosarcoma Trial in United States (TTI-621, Doxorubicin)

Recruiting
  • Leiomyosarcoma
  • Santa Monica, California
  • +26 more
Jul 26, 2022

Metastatic Lung Cancer Trial in France (InvisionFirst® molecular panel)

Active, not recruiting
  • Metastatic Lung Cancer
  • InvisionFirst® molecular panel
  • Bayeux, France
  • +15 more
Aug 22, 2022

Smart Textile Sensor System for Health Monitoring

Recruiting
  • Heart Disease Chronic
  • +3 more
  • Nanowear SimpleSense Wearable monitoring device
  • Atlanta, Georgia
  • +2 more
Jul 22, 2022

Atrial Fibrillation After Cryoballoon Ablation

Not yet recruiting
  • Atrial Fibrillation
  • cryoballoon ablation
  • (no location specified)
Aug 6, 2022

Mild to Moderate TBI, PTSD Trial in San Diego (TTI-0102, Placebo)

Withdrawn
  • Mild to Moderate TBI
  • Posttraumatic Stress Disorder
  • San Diego, California
    VA San Diego Healthcare System, San Diego, CA
Oct 18, 2021

Acute Ebola Virus Disease Trial in Atlanta, Omaha (INTERCEPT Plasma)

Terminated
  • Acute Ebola Virus Disease
  • INTERCEPT Plasma
  • Atlanta, Georgia
  • +1 more
Mar 26, 2021

Solid Tumors, Mycosis Fungoides, Melanoma Trial in United States (TTI-621 Monotherapy, TTI-621 + PD-1/PD-L1 Inhibitor, TTI-621 +

Terminated
  • Solid Tumors
  • +7 more
  • TTI-621 Monotherapy
  • +4 more
  • Duarte, California
  • +6 more
May 13, 2020

Diffuse Large B Cell Lymphoma,DLBCL Trial in Chengdu (PM 8.4 mg/m2, PM 11.2 mg/m2)

Recruiting
  • Diffuse Large B Cell Lymphoma,DLBCL
  • PM 8.4 mg/m2
  • PM 11.2 mg/m2
  • Chengdu, Sichuan, China
    West China Hospital Sichuan University
Jan 15, 2023

Hypertensive Disorder of Pregnancy, Pregnancy Complications, Pre-Eclampsia Trial in Kingston, Montreal (Breastfeeding

Recruiting
  • Hypertensive Disorder of Pregnancy
  • +4 more
  • Breastfeeding self-efficacy (BSE)
  • Kingston, Ontario, Canada
  • +1 more
Aug 27, 2021

Atrial Fibrillation Trial in Lódz (Cryoballoon pulmonary vein isolation)

Unknown status
  • Atrial Fibrillation
  • Cryoballoon pulmonary vein isolation
  • Łódź, Łódzkie, Poland
    Uniwersytecki Szpital Kliniczny im. Wojskowej Akademii Medycznej
Nov 13, 2019

Ballistocardiographic Biosensors and Other Hemodynamic Measures

Completed
  • Hemodynamics
  • +2 more
  • Biosensors
  • Oslo, Please Select, Norway
    Oslo University Hospital
Oct 7, 2020